LB Pharmaceuticals (LBRX) Earnings Date & Reports

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LBRX is expected to report earnings to fall 42.11% to -99 cents per share on November 05

LB Pharmaceuticals LBRX Stock Earnings Reports

Q3'26

Est.

$-0.99

Q2'26

Missed

by $0.93

Q1'26

Missed

by $0.17

Q4'25

Beat

by $0.13

The last earnings report on August 11 showed earnings per share of -171 cents, missing the estimate of -77 cents. With 208.35K shares outstanding, the current market capitalization sits at 1.22B.

View a ticker or compare two or three

LBRX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for LBRX